Carregant...
Thrombotic microangiopathy and human immunodeficiency virus in the era of eculizumab
Thrombotic microangiopathies (TMAs) include thrombotic thromobocytopenic purpura and hemolytic uremic syndrome (HUS). Among these conditions, atypical HUS is now recognized to be a disease of alternative complement pathway dysregulation. Eculizumab is a recombinant humanized monoclonal antibody that...
Guardat en:
| Publicat a: | Clin Kidney J |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Oxford University Press
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4957717/ https://ncbi.nlm.nih.gov/pubmed/27478600 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ckj/sfw035 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|